IPO News | CSPC Innovation (300765.SZ) submitted to the Hong Kong Stock Exchange

The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on December 10, CSPC Pharmaceutical Co., Ltd. (abbreviation: CSPC Innovation, 300765.SZ) submitted a listing application to the main board of the Hong Kong Stock Exchange, and CITIC Securities is its sole sponsor. According to the prospectus, the company focuses on R&D, production and commercialization of biopharmaceuticals, functional ingredients and health foods. According to Frost & Sullivan, from 2020 to 2024, the company maintained its position as the world's largest producer of chemically synthesized caffeine in terms of revenue and shipments.

Since its establishment in 2006, the company has focused on the development and production of high-quality caffeine. The company mainly produces caffeine, which is used as a food additive in functional drinks. According to Frost & Sullivan, from 2020 to 2024, the company maintained its position as the world's largest producer of chemically synthesized caffeine in terms of revenue and shipments. As of the last practical date (December 1, 2025), the company's products have been sold to 65 countries and regions around the world, and the company's main markets are North America and Europe. With stable product quality, cost advantages brought about by large-scale production, and a perfect supply chain system, the company has established stable cooperative relationships with leading customers in the international beverage industry. The company is a global caffeine supplier to industry giants such as Coca Cola (since 2006), Pepsi (since 2007), and RedBullGMBH (since 2008).